Views
14
Downloands
1
Motor nöron hastalığının prototipi olan Amiyotrofik lateral Skleroz (ALS) patogenezinin tam olarak anlaşılamamış olması ve hastalığın yüz güldürücü bir tedavisinin olmaması tanı sürecini hasta ve hekim için endişe verici hale getirmektedir. ALS patogenezinde yer alan süreçlerin her birine ilişkin bir çok farklı ajan denense de günümüzde belli ülkelerde onay alarak kendine yer bulmuş olan ajanlar riluzol ve edaravondur.
The pathogenesis of the prototype of motor neuron diseases, Amyotrophic Lateral Sclerosis (ALS), is not fully understood and the lack of a satisfactory treatment of the disease makes the diagnosis process worrying for the patient and the physician. Although many agents are used for each of the processes in ALS pathogenesis, riluzol and edaravone are the agents that have found their place in certain countries.
The pathogenesis of the prototype of motor neuron diseases, Amyotrophic Lateral Sclerosis (ALS), is not fully understood and the lack of a satisfactory treatment of the disease makes the diagnosis process worrying for the patient and the physician. Although many agents are used for each of the processes in ALS pathogenesis, riluzol and edaravone are the agents that have found their place in certain countries.
Field : Sağlık Bilimleri
Journal Type : Uluslararası
Article Detail 
Similar Articles
Download PDF
Journal Information
Listen Paper
Cite
Print This Page
Share
Mendeley
